Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
PUT
Sprott Uranium Miners ETF
URNM
$2B
| $3.57M | ﹤0.01% |
88,600
-66,300
| -43% | -$3.09M |
|
4502
Shake Shack
SHAK
$3.02B
| $3.57M | ﹤0.01% |
27,513
-288,345
| -91% | -$35.3M |
|
4503
CALL
Banco Macro
BMA
$4.96B
| $3.57M | ﹤0.01% |
36,900
-55,500
| -60% | -$4.55M |
|
|
NFBK
4504
DELISTED
Northfield Bancorp
NFBK
| $3.57M | ﹤0.01% |
307,152
-11,373
| -4% | -$141K |
|
4505
CALL
AllianceBernstein
AB
$3.41B
| $3.56M | ﹤0.01% |
96,100
-93,800
| -49% | -$3.42M |
|
4506
PUT
Aurinia Pharmaceuticals
AUPH
$2.06B
| $3.56M | ﹤0.01% |
396,400
-18,300
| -4% | -$149K |
|
4507
Atara Biotherapeutics
ATRA
$81.2M
| $3.56M | ﹤0.01% |
267,353
+6,873
| +3% | +$72.4K |
|
4508
Apollo Global Management
APO
$83.1B
| $3.56M | ﹤0.01% |
21,540
-1,700,084
| -99% | -$269M |
|
|
ODP
4509
DELISTED
ODP
ODP
| $3.55M | ﹤0.01% |
156,255
+152,952
| +4,631% | +$4.26M |
|
4510
PUT
Navient
NAVI
$860M
| $3.55M | ﹤0.01% |
267,200
-154,200
| -37% | -$2.31M |
|
4511
CALL
Kinetik
KNTK
$4.3B
| $3.55M | ﹤0.01% |
62,600
-42,300
| -40% | -$2.29M |
|
4512
PUT
SLM Corp
SLM
$5.27B
| $3.55M | ﹤0.01% |
128,700
+106,200
| +472% | +$2.63M |
|
|
SEE
4513
DELISTED
Sealed Air
SEE
| $3.55M | ﹤0.01% |
104,919
-213,784
| -67% | -$7.63M |
|
4514
Canadian Imperial Bank of Commerce
CM
$113B
| $3.55M | ﹤0.01% |
56,117
+28,151
| +101% | +$1.79M |
|
4515
CALL
Expeditors International
EXPD
$24.2B
| $3.54M | ﹤0.01% |
32,000
-16,800
| -34% | -$2M |
|
4516
PUT
Eversource Energy
ES
$27.2B
| $3.54M | ﹤0.01% |
61,700
+3,800
| +7% | +$237K |
|
4517
CALL
iShares US Medical Devices ETF
IHI
$3.46B
| $3.54M | ﹤0.01% |
60,700
-29,000
| -32% | -$1.72M |
|
4518
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.38B
| $3.54M | ﹤0.01% |
147,127
+87,495
| +147% | +$2.11M |
|
4519
CALL
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.79B
| $3.54M | ﹤0.01% |
81,800
+19,700
| +32% | +$894K |
|
4520
ProShares Short S&P500
SH
$841M
| $3.54M | ﹤0.01% |
83,447
+14,392
| +21% | +$613K |
|
4521
PUT
Roper Technologies
ROP
$39.5B
| $3.53M | ﹤0.01% |
6,800
-9,300
| -58% | -$5.11M |
|
4522
CALL
Brink's
BCO
$4.71B
| $3.53M | ﹤0.01% |
38,100
-36,700
| -49% | -$3.67M |
|
4523
Mativ Holdings
MATV
$674M
| $3.53M | ﹤0.01% |
324,257
-241,628
| -43% | -$3.37M |
|
4524
ProShares UltraShort QQQ
QID
$242M
| $3.52M | ﹤0.01% |
107,825
-24,230
| -18% | -$822K |
|
4525
ProShares Short QQQ
PSQ
$636M
| $3.52M | ﹤0.01% |
94,227
-113,443
| -55% | -$4.34M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.